CANF
Price
$1.10
Change
-$0.05 (-4.35%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
15.95M
OABI
Price
$1.85
Change
+$0.05 (+2.78%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
219.84M
Ad is loading...

CANF vs OABI

Header iconCANF vs OABI Comparison
Open Charts CANF vs OABIBanner chart's image
Can-Fite BioPharma
Price$1.10
Change-$0.05 (-4.35%)
Volume$100
Capitalization15.95M
OmniAb
Price$1.85
Change+$0.05 (+2.78%)
Volume$13.14K
Capitalization219.84M
CANF vs OABI Comparison Chart
Loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANF vs. OABI commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Hold and OABI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (CANF: $1.15 vs. OABI: $1.80)
Brand notoriety: CANF and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 21% vs. OABI: 131%
Market capitalization -- CANF: $15.95M vs. OABI: $219.84M
CANF [@Biotechnology] is valued at $15.95M. OABI’s [@Biotechnology] market capitalization is $219.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • CANF’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, both CANF and OABI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 2 TA indicator(s) are bullish while OABI’s TA Score has 5 bullish TA indicator(s).

  • CANF’s TA Score: 2 bullish, 5 bearish.
  • OABI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, OABI is a better buy in the short-term than CANF.

Price Growth

CANF (@Biotechnology) experienced а -7.26% price change this week, while OABI (@Biotechnology) price change was -1.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

CANF is expected to report earnings on Apr 14, 2025.

OABI is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OABI($220M) has a higher market cap than CANF($15.9M). CANF YTD gains are higher at: -29.231 vs. OABI (-49.153). OABI has more cash in the bank: 59.4M vs. CANF (995K). CANF has less debt than OABI: CANF (40K) vs OABI (23.2M).
CANFOABICANF / OABI
Capitalization15.9M220M7%
EBITDAN/A-50.92M-
Gain YTD-29.231-49.15359%
P/E RatioN/AN/A-
RevenueN/A26.4M-
Total Cash995K59.4M2%
Total Debt40K23.2M0%
FUNDAMENTALS RATINGS
CANF: Fundamental Ratings
CANF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CANFOABI
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
66%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

CANF and

Correlation & Price change

A.I.dvisor tells us that CANF and LGVN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANF and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
+1.77%
LGVN - CANF
32%
Poorly correlated
-5.71%
OABI - CANF
30%
Poorly correlated
+2.27%
GBIO - CANF
29%
Poorly correlated
+1.01%
RNA - CANF
29%
Poorly correlated
+1.18%
KYTX - CANF
27%
Poorly correlated
-2.38%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with NAUT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+2.27%
NAUT - OABI
40%
Loosely correlated
-1.22%
ALEC - OABI
40%
Loosely correlated
+1.75%
NTLA - OABI
38%
Loosely correlated
+2.05%
BEAM - OABI
37%
Loosely correlated
+1.43%
AURA - OABI
37%
Loosely correlated
+2.42%
More